MicroOptx

About:

MicroOptx is an early-stage medical device company that leverages academic bioengineering.

Website: http://www.microoptx.com/

Top Investors: HBM Healthcare Investments

Description:

MicroOptx is an early-stage medical device company that leverages academic bioengineering, surgical expertise, microengineering manufacturing, and nanotechnology to provide the modern solution for the vexing problem of Glaucoma. It develops a platform technology to shunt aqueous humor from the anterior chamber to the surface of the eye. The company is driven by a mission is to change the way the world treats glaucoma: and to halt the devastating effects of this progressive disease. MicroOptx is led by recognized medical, industry and financial veterans who are dedicated to preventing blindness.

Total Funding Amount:

$19.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Maple Grove, Minnesota, United States

Founded Date:

2014-01-01

Contact Email:

cpulling(AT)microoptx.com

Founders:

Chris Pulling, Roy Martin

Number of Employees:

11-50

Last Funding Date:

2019-08-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai